Aerpace Industries director resigns due to health reasons

1 min read     Updated on 09 Jun 2026, 02:35 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Aerpace Industries Limited announced the resignation of Mr. Virendra Singh Verma as Non-Executive Independent Director effective June 9, 2026, due to health reasons. He confirmed no other material reasons for his departure and ceased to be a member of the Audit Committee and Nomination & Remuneration Committee.

powered bylight_fuzz_icon
42541527

*this image is generated using AI for illustrative purposes only.

Aerpace Industries Limited announced the resignation of Mr. Virendra Singh Verma from the position of Non-Executive Independent Director, effective June 9, 2026. The resignation, attributed to health reasons, was submitted to the Board and necessitates cessation from his roles on key board committees. This development impacts the company's governance structure as Verma steps down from the Audit Committee and Nomination & Remuneration Committee.

The company disclosed the event in a filing submitted to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Managing Director & CFO, Anand Manoj Shah, confirmed that the resignation took effect from the close of business hours on June 9, 2026. The filing included an annexure detailing the specific reasons for the change and confirming compliance with regulatory requirements.

Mr. Virendra Singh Verma explicitly stated that health concerns preventing him from effectively discharging his duties were the sole reason for his departure. He confirmed that there are no other material reasons for the resignation beyond those cited in his formal letter. The director also requested the Board to facilitate the necessary filings with the Registrar of Companies and stock exchanges.

Prior to his resignation, Mr. Virendra Singh Verma held directorships in other listed entities, including Reliance Infrastructure Limited, where he served as an Independent Director. His involvement at Aerpace Industries Limited included membership in the Audit Committee and the Nomination & Remuneration Committee, roles he vacated effective immediately upon his resignation.

The following table summarizes the key details of the director's cessation:

Particulars Details
Name of Director Mr. Virendra Singh Verma
Designation Non-Executive Independent Director
Reason for Resignation Health reasons
Date of Cessation June 9, 2026
Committee Membership Ceased Audit Committee, Nomination & Remuneration Committee

Historical Stock Returns for Aerpace Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+2.34%+14.43%+2.30%+34.29%-8.87%+107.69%

What is the timeline for appointing a successor to fill the vacancy in the Audit Committee?

How will the company ensure continuity in governance during the transition period?

Will the resignation impact Aerpace Industries' strategic decisions or upcoming board meetings?

Aerpace Industries Reports Audited Standalone & Consolidated Financial Results for Quarter and Year Ended March 31, 2026

3 min read     Updated on 13 May 2026, 04:57 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Aerpace Industries Limited disclosed its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, approved by the Board on May 11, 2026. Standalone total income from operations grew to ₹403.96 lakhs for FY26, but the net loss after tax widened sharply to ₹1,200.29 lakhs from ₹483.67 lakhs in FY25. On a consolidated basis, the net loss after tax for FY26 stood at ₹1,650.30 lakhs, compared to ₹739.43 lakhs in the prior year. The company reported no exceptional or extraordinary items for any of the periods disclosed.

powered bylight_fuzz_icon
40217236

*this image is generated using AI for illustrative purposes only.

Aerpace Industries Limited has published its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were published in Active Times (English) and Mumbai Lakshadeep (Marathi) on May 13, 2026, and were approved by the Board of Directors at their meeting held on May 11, 2026.

Standalone Financial Performance

On a standalone basis, Aerpace Industries reported total income from operations of ₹403.96 lakhs for the year ended March 31, 2026, compared to ₹302.06 lakhs in the previous year. However, losses deepened significantly during the period. The standalone net loss after tax (after exceptional and/or extraordinary items) for the full year stood at ₹1,200.29 lakhs, against ₹483.67 lakhs in the year ended March 31, 2025. For the quarter ended March 31, 2026, standalone total income from operations was ₹114.10 lakhs, while the net loss after tax was ₹669.38 lakhs.

The following table summarises the key standalone financial metrics:

Metric: Q4 FY26 (31.03.2026) Q3 FY26 (31.12.2025) Q4 FY25 (31.03.2025) FY26 (Year Ended 31.03.2026) FY25 (Year Ended 31.03.2025)
Total Income from Operations (₹ lakhs): 114.10 95.89 97.85 403.96 302.06
Net Profit/(Loss) before Tax (₹ lakhs): (674.88) (216.10) (169.66) (1,222.55) (495.69)
Net Profit/(Loss) after Tax (₹ lakhs): (669.38) (212.30) (162.97) (1,200.29) (483.67)
Total Comprehensive Income (₹ lakhs): (669.38) (213.21) (160.41) (1,199.43) (481.29)
Equity Share Capital (₹ lakhs): 1,538.58 1,538.58 1,538.58 1,538.58 1,538.58
Basic EPS (₹ 1/- each, not annualised): (0.44) (0.14) (0.11) (0.78) (0.33)
Diluted EPS (₹ 1/- each, not annualised): (0.44) (0.14) (0.11) (0.78) (0.33)

Consolidated Financial Performance

On a consolidated basis, total income from operations for the year ended March 31, 2026 was ₹59.44 lakhs, compared to ₹22.13 lakhs for the quarter ended March 31, 2025. The consolidated net loss after tax for the full year stood at ₹1,650.30 lakhs, against ₹490.40 lakhs in the prior year. For the quarter ended March 31, 2026, consolidated total income from operations was ₹4.04 lakhs, with a net loss after tax of ₹892.79 lakhs.

The following table presents the key consolidated financial metrics:

Metric: Q4 FY26 (31.03.2026) Q3 FY26 (31.12.2025) Q4 FY25 (31.03.2025) FY26 (Year Ended 31.03.2026) FY25 (Year Ended 31.03.2025)
Total Income from Operations (₹ lakhs): 4.04 2.11 40.66 59.44 22.13
Net Profit/(Loss) before Tax (₹ lakhs): (900.86) (238.94) (496.77) (1,674.97) (751.62)
Net Profit/(Loss) after Tax (₹ lakhs): (892.79) (235.98) (490.40) (1,650.30) (739.43)
Total Comprehensive Income (₹ lakhs): (892.92) (236.55) (488.02) (1,649.13) (737.11)
Equity Share Capital (₹ lakhs): 1,538.58 1,538.58 1,538.58 1,538.58 1,538.58
Basic EPS (₹ 1/- each, not annualised): (0.58) (0.15) (0.33) (1.07) (0.50)
Diluted EPS (₹ 1/- each, not annualised): (0.58) (0.15) (0.33) (1.07) (0.50)

Regulatory Compliance and Disclosure

The financial results were reviewed by the Audit Committee and subsequently approved by the Board of Directors at their meeting on May 11, 2026. The company confirmed that there are no exceptional or extraordinary items to report for any of the periods covered. The results represent an extract of the detailed statements filed with the stock exchange under Regulation 33 of the SEBI Listing Regulations. The full format of the audited standalone and consolidated financial results is available on the BSE website ( www.bseindia.com ) and on the company's website ( www.aerpace.com ). The disclosure was signed by Anand Manoj Shah, Managing Director & CFO (DIN: 11709310), on behalf of the Board of Directors of Aerpace Industries Limited.

Historical Stock Returns for Aerpace Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+2.34%+14.43%+2.30%+34.29%-8.87%+107.69%

What specific restructuring or turnaround strategies is Aerpace Industries' management planning to implement to reverse the accelerating losses, given that the standalone net loss nearly tripled year-over-year to ₹1,200.29 lakhs?

How long can Aerpace Industries sustain operations given the widening gap between its consolidated revenue of ₹59.44 lakhs and consolidated net losses of ₹1,650.30 lakhs, and is the company at risk of triggering SEBI's insolvency or delisting provisions?

What is driving the significant divergence between standalone revenue (₹403.96 lakhs) and consolidated revenue (₹59.44 lakhs), and what does this imply about the financial health and viability of Aerpace's subsidiaries?

More News on Aerpace Industries

1 Year Returns:-8.87%